Patents for A61L 27 - Materials for prostheses or for coating prostheses (57,339)
03/2005
03/24/2005WO2005025520A2 Chitosan spinning method, device therefor, and resulting chitosan yarn, and uses thereof
03/24/2005WO2005025493A2 Biological engineering of articular structures containing both cartilage and bone
03/24/2005WO2005025451A2 Method and materials for interpositional arthroplasty implant
03/24/2005WO2005010172A3 Aligned scaffolds for improved myocardial regeneration
03/24/2005WO2005009498A3 Decellularized bone marrow extracellular matrix
03/24/2005WO2005004945A3 Thermal treatment of a drug eluting implantable medical device
03/24/2005WO2005004942A3 Injectable composite for the magnetocytolysis of bone metastatic cells
03/24/2005WO2004093751A3 Vertebral body and disc space replacement devices
03/24/2005WO2004085098A3 Metallic nanoparticles as orthopedic biomaterial
03/24/2005WO2004066867A3 Solid implant
03/24/2005WO2004017972A8 Biologic skin repair and enhancement
03/24/2005WO2003045973A8 Peptides with growth inhibitory action
03/24/2005US20050066379 Preparing somatic embryo by utilizing rabbit oocyte
03/24/2005US20050065616 Implantable hydrogel with resorbable shell for use as an endoprothesis
03/24/2005US20050065604 Surgical implant
03/24/2005US20050065595 Implants containing combretastatin a-4
03/24/2005US20050065307 Wherein at least some of the ultrahigh molecular weight polyethylene comprises hydrophilic functional groups attached thereto; provides a substrate suitable for bone in-growth and/or soft tissue in-growth
03/24/2005US20050065281 Use of biomaterials which act as three dimensional scaffolds or matrices (with or without bioactive factors attached) for wound healing applications and tissue regeneration
03/24/2005US20050065084 polynucleotide codes for saratin polypeptides from saliva of leeches, used as antagonist for collagen-dependent platelet adhesion; genetic engineering; prophylaxis of cardiovascular disorders
03/24/2005US20050065083 Promoting survival of nerve cells; stimulating cell differentiation; amyotropic lateral scleerosis
03/24/2005US20050064591 Washing heart tissue in alcohol, water and glycosidase to remove carbohydrate moieties in preparation of engraftment in human; tissue repair and engineering; transplantation
03/24/2005US20050064210 Coating for use with medical devices and method of making same
03/24/2005US20050064176 Such as an overcoated urinary catheters, condoms, and contact lenses
03/24/2005US20050064042 Cartilage implant plug with fibrin glue and method for implantation
03/24/2005US20050064038 Two or more active agents (drugs) in a layer of a miscible polymer blend where delivery of one active agent occurs faster due to its greater permeability than the other drugs; medical devices such as stents; versatility in mechanical properties, active agents
03/24/2005US20050064011 biostable drug delivery devices having antioxidants, used for prevention of cardiovascular disorders
03/24/2005US20050064007 Surface-modified implants
03/24/2005US20050064005 Active agent delivery systems including a miscible polymer blend, medical devices, and methods
03/24/2005US20050063959 By transfection with an an osteo-/chondro-inducible transcription factor gene such as Cbfa1, Dlx-5, Bapx1, Msx2, Scleraxis, or Sox9, and allowing the cells to differentiate and proliferate on a scaffold; implants
03/24/2005US20050063941 Biodegradable polymeric material for biomedical applications
03/24/2005US20050063937 Multiple-arm peptide compounds, methods of manufacture and use in therapy
03/24/2005DE10339170A1 Intervertebral implant useful as replacement for intervertebral disk, includes upper and lower support bodies that are supported pivotably in relation to one another via saddle joint
03/24/2005DE10332072A1 Individuell anpassbares Wirkstofffreisetzungssystem Individually customizable drug release system
03/24/2005CA2537735A1 Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
03/24/2005CA2537207A1 Prepolymers with yellow dye moiety
03/24/2005CA2536730A1 Intraocular lens with blue light absorption properties and process
03/24/2005CA2533777A1 Lubricious coating
03/23/2005EP1516922A1 Apparatus for use in the regeneration of structured human tissue
03/23/2005EP1516882A1 Composition containing a marine-derived inorganic substance and chitin/chitosan, and method of producing the composition
03/23/2005EP1516637A1 Medical implant or medical implant part comprising porous UHMWPE and process for producing the same
03/23/2005EP1516636A2 Use of a curable elastomer-precursor for a medical treatment
03/23/2005EP1516635A1 Artificial bone and tissue engineering carrier
03/23/2005EP1516602A2 Implant with bioactive particles stuck and method of manufacturing the same
03/23/2005EP1516599A2 A transmyocardial implant
03/23/2005EP1516597A1 Drug eluting stent
03/23/2005EP1516071A1 Method for manufacturing superelastic beta titanium articles and the articles derived therefrom
03/23/2005EP1516070A1 Titanium compositions and methods of manufacture thereof
03/23/2005EP1516014A1 Porous gelatin material, gelatin structures, methods for preparation of the same and uses thereof
03/23/2005EP1516003A1 Linear block polymer
03/23/2005EP1515759A1 An osteointegrative interface for implantable prostheses and method for its manufacture
03/23/2005EP1515758A1 Open-pored metal coating for joint replacement implants and method for production thereof
03/23/2005EP1515757A1 Prosthetic devices having diffusion-hardened surfaces and bioceramic coatings
03/23/2005EP1515673A2 Methods and systems for performing vitrectomy with continuous perfluorocarbon infusion
03/23/2005EP1515657A1 Bone fixing element
03/23/2005EP1493454A9 Biomaterials for nerve reconstruction and process for producing the same
03/23/2005EP1343542B1 Carrier with solid fibrinogen and solid thrombin
03/23/2005EP1330176A4 METHOD FOR i IN VIVO /i , i EX VIVO /i AND i IN VITRO /i REPAIR AND REGENERATION OF CARTILAGE AND COLLAGEN AND BONE REMODELING
03/23/2005EP1199049B1 Metallic composite surface composition for an implant structure
03/23/2005EP1185312B1 Biomaterials modified with superoxide dismutase mimics
03/23/2005EP1079869B1 Synthesis of poly(propylene fumarate) by acylation of propylene glycol in the presence of a proton scavenger
03/23/2005CN1599793A Chondrocyte precursors derived from human embryonic stem cells
03/23/2005CN1599629A Resorbable polymer composition, implant and method of making implant
03/23/2005CN1599619A Methods and compositions for treating dermal lesions
03/23/2005CN1599582A Vascular prosthesis and method for production thereof
03/23/2005CN1597937A Extracting material of placental villi cell and its application for inducing differentiating of matrax stem cell
03/23/2005CN1597590A Calcium phoshate bone cement powder containing traditional Chinese medicine and its preparation method
03/23/2005CN1596996A Mentula elongation implantation substance
03/23/2005CN1596995A Osseous tissue engineering stent material and its preparation method
03/23/2005CN1596994A Bone tissue repairing filler and its preparation material
03/23/2005CN1596993A Artificial peripheral nerve containing substance for promoting peripheral nerve regeneration
03/23/2005CN1193802C Double-layered artificial skin and its prepn process
03/23/2005CN1193801C Method for preparing tissue engineering cell cytoskeletay and products obtained by said method
03/23/2005CN1193800C Artificial dura
03/23/2005CN1193799C porous material for repairing bone
03/22/2005US6869701 Self-repairing ceramic coatings
03/22/2005US6869619 Tissue regenerative composition, method of making, and method of use thereof
03/22/2005US6869450 Subcutaneous, intramuscular support for a rigid transcutaneous implant
03/22/2005US6869445 Packable ceramic beads for bone repair
03/22/2005US6869433 Polyaxial screw with improved locking
03/22/2005CA2482116A1 Apparatus for use in the regeneration of structured human tissue
03/22/2005CA2133974C Fibrin coated polymer surfaces
03/17/2005WO2005023996A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS
03/17/2005WO2005023331A2 Hydrogel nanocompsites for ophthalmic applications
03/17/2005WO2005023326A1 Implantation material compatible with organism and method for preparation thereof
03/17/2005WO2005023325A1 Structural body constituted of biocompatible material impregnated with fine bone dust and process for producing the same
03/17/2005WO2005023324A1 Meniscal superfacial zone cells for articular cartilage repair
03/17/2005WO2005023323A1 Gelled biopolymer based foam
03/17/2005WO2005023321A2 Extracellular matrix composite materials, and manufacture and use thereof
03/17/2005WO2005023156A1 Allogenic/xenogenic implants and methods for augmenting or repairing intervertebral discs
03/17/2005WO2004111643A3 Patterns for a skeletal system
03/17/2005US20050060043 Medial/distal tip for artificial joint
03/17/2005US20050060033 Tissue engineered tendons and ligaments
03/17/2005US20050060028 Blood biocompatible layer and adjacent layer containing antiproliferative, antiinflammatory and/or antithrombotic active agent covalently and/or adhesively bound
03/17/2005US20050059994 Fatigue resistant medical devices
03/17/2005US20050059750 Irradiated ultra-high molecular weight polyethylene having a FTIR (Fourier Transform Infra-red Spectroscopy) oxidation index which does not increase with oven aging; increased oxidation resistance
03/17/2005US20050058844 Method for making medical devices having antimicrobial coatings thereon
03/17/2005US20050058835 Impregnating the device or material with a precursor compound that is capable of being decomposed in-situ in the device or material to yield active antimicrobial substance, the precursor being impregnated into the device as a solution, an emulsion or a suspension in the supercritical fluid, decomposing
03/17/2005US20050058726 Incubating bone to loosene associated soft tissue with alkaline solution comprising hydroxide of sodium, potassium, ammonium, or lithium; and/or trisodium phosphate, tripotassioum phosphate and/or triethanolamine
03/17/2005US20050058715 Composition containing a marine-derived inorganic substance and chitin/chitosan, and method of producing the composition
03/17/2005US20050058692 Biofunctional fibers